Biomarker analysis from the phase 2b randomized placebo-controlled trial of riociguat in early diffuse cutaneous systemic sclerosis

Dinesh Khanna, Frank Kramer, Josef Höfler, Mercedeh Ghadessi, Peter Sandner, Yannick Allanore, Christopher P Denton, Masataka Kuwana, Marco Matucci-Cerinic, Janet E Pope, Tatsuya Atsumi, Radim Bečvář, László Czirják, Ellen De Langhe, Eric Hachulla, Tomonori Ishii, Osamu Ishikawa, Sindhu R Johnson, Valeria Riccieri, Elena Schiopu, Richard M Silver, Vanessa Smith, Chiara Stagnaro, Virginia Steen, Wendy Stevens, Gabriella Szücs, Marie-Elise Truchetet, Melanie Wosnitza, Oliver Distler

Open source

DOI: 10.1093/rheumatology/keae150
Published: 2024-03-09
Container: Rheumatology
Publisher: Oxford University Press (OUP)
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1093/rheumatology/keae150,
  title = {Biomarker analysis from the phase 2b randomized placebo-controlled trial of riociguat in early diffuse cutaneous systemic sclerosis},
  author = {Dinesh Khanna and Frank Kramer and Josef Höfler and Mercedeh Ghadessi and Peter Sandner and Yannick Allanore and Christopher P Denton and Masataka Kuwana and Marco Matucci-Cerinic and Janet E Pope and Tatsuya Atsumi and Radim Bečvář and László Czirják and Ellen De Langhe and Eric Hachulla and Tomonori Ishii and Osamu Ishikawa and Sindhu R Johnson and Valeria Riccieri and Elena Schiopu and Richard M Silver and Vanessa Smith and Chiara Stagnaro and Virginia Steen and Wendy Stevens and Gabriella Szücs and Marie-Elise Truchetet and Melanie Wosnitza and Oliver Distler},
  year = {2024},
  journal = {Rheumatology},
  doi = {10.1093/rheumatology/keae150},
  url = {https://doi.org/10.1093/rheumatology/keae150}
}

RIS

TY  - JOUR
TI  - Biomarker analysis from the phase 2b randomized placebo-controlled trial of riociguat in early diffuse cutaneous systemic sclerosis
AU  - Dinesh Khanna
AU  - Frank Kramer
AU  - Josef Höfler
AU  - Mercedeh Ghadessi
AU  - Peter Sandner
AU  - Yannick Allanore
AU  - Christopher P Denton
AU  - Masataka Kuwana
AU  - Marco Matucci-Cerinic
AU  - Janet E Pope
AU  - Tatsuya Atsumi
AU  - Radim Bečvář
AU  - László Czirják
AU  - Ellen De Langhe
AU  - Eric Hachulla
AU  - Tomonori Ishii
AU  - Osamu Ishikawa
AU  - Sindhu R Johnson
AU  - Valeria Riccieri
AU  - Elena Schiopu
AU  - Richard M Silver
AU  - Vanessa Smith
AU  - Chiara Stagnaro
AU  - Virginia Steen
AU  - Wendy Stevens
AU  - Gabriella Szücs
AU  - Marie-Elise Truchetet
AU  - Melanie Wosnitza
AU  - Oliver Distler
PY  - 2024
JO  - Rheumatology
DO  - 10.1093/rheumatology/keae150
UR  - https://doi.org/10.1093/rheumatology/keae150
ER  -

APA

Khanna, D., Kramer, F., Höfler, J., Ghadessi, M., Sandner, P., Allanore, Y., Denton, C. P., Kuwana, M., Matucci-Cerinic, M., Pope, J. E., Atsumi, T., Bečvář, R., Czirják, L., Langhe, E. D., Hachulla, E., Ishii, T., Ishikawa, O., Johnson, S. R., Riccieri, V., Schiopu, E., Silver, R. M., Smith, V., Stagnaro, C., Steen, V., Stevens, W., Szücs, G., Truchetet, M., Wosnitza, M., & Distler, O. (2024). Biomarker analysis from the phase 2b randomized placebo-controlled trial of riociguat in early diffuse cutaneous systemic sclerosis. Rheumatology. https://doi.org/10.1093/rheumatology/keae150

Source records

crossref · retrieved 2026-09-26T11:25:21.714Z